Gut bacteria supplement for mild Crohn's disease
Part of Digestive system clinical trials.
This trial tests a specially formulated supplement (sodium propionate) to see if it can improve the balance of bacteria in your gut, which may help control Crohn's disease. It's for people with mild or inactive Crohn's who want to explore a new way to support their gut health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Crohn's disease (not ulcerative colitis).
- Your Crohn's is in remission or mild—you don't have severe symptoms.
- You had a colonoscopy within the last 2 months that confirms your diagnosis.
- You are between 18 and 75 years old.
- You have not tested positive for C. diff infection.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a specific probiotic (a type of beneficial bacteria) to see if it can help people with mild to moderate ulcerative colitis by improving the balance of gut microbes. It may be an option if you have not used many advanced treatments before.
This trial tests whether a prebiotic supplement can improve symptoms of ulcerative colitis. It may be a good option for people with active symptoms who are already on stable medications.
This study tests whether a special diet using a nutritional supplement can reduce inflammation and improve symptoms in people with active Crohn's disease affecting the small intestine. It aims to see how the diet changes gut bacteria and body composition.
This study tests if a standardized fecal transplant is safe and helpful for adults with moderately to severely active Crohn's disease who are already on maintenance therapy. The goal is to see if this treatment can reduce inflammation in the digestive tract.
This trial tests a bacteria called Clostridium butyricum to see if it can help people with a type of Crohn's disease that causes narrowing in the right colon or ileocecal area. It may offer a new option for those not on strong immune-suppressing medications.
This trial tests whether taking sodium butyrate (a short-chain fatty acid) and a specific probiotic yeast called Kluyveromyces marxianus can help keep ulcerative colitis in remission and prevent flare-ups. You'd need to be in remission (symptom-free with no active inflammation) when you start.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.